GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 27.932
AS - Asia 12.268
EU - Europa 10.049
SA - Sud America 1.581
Continente sconosciuto - Info sul continente non disponibili 343
AF - Africa 312
OC - Oceania 44
Totale 52.529
Nazione #
US - Stati Uniti d'America 27.426
SG - Singapore 3.856
GB - Regno Unito 3.515
CN - Cina 3.322
IT - Italia 2.098
HK - Hong Kong 1.450
BR - Brasile 1.221
VN - Vietnam 1.168
SE - Svezia 824
DE - Germania 784
UA - Ucraina 595
FI - Finlandia 571
BD - Bangladesh 541
TR - Turchia 462
RU - Federazione Russa 406
FR - Francia 361
KR - Corea 330
IN - India 249
CA - Canada 236
BG - Bulgaria 224
MX - Messico 130
ID - Indonesia 125
AR - Argentina 118
ES - Italia 113
IQ - Iraq 105
NL - Olanda 104
PK - Pakistan 100
PL - Polonia 90
JP - Giappone 85
ZA - Sudafrica 79
IE - Irlanda 73
AE - Emirati Arabi Uniti 55
EG - Egitto 55
EC - Ecuador 52
IR - Iran 47
PH - Filippine 46
MA - Marocco 45
CO - Colombia 43
AU - Australia 40
LT - Lituania 39
VE - Venezuela 39
MY - Malesia 37
CL - Cile 36
TH - Thailandia 35
SA - Arabia Saudita 32
BE - Belgio 29
KE - Kenya 27
PE - Perù 27
UZ - Uzbekistan 27
CH - Svizzera 25
DZ - Algeria 24
JM - Giamaica 24
RO - Romania 23
TN - Tunisia 23
AT - Austria 21
AZ - Azerbaigian 20
IL - Israele 20
UY - Uruguay 20
CZ - Repubblica Ceca 19
JO - Giordania 18
PT - Portogallo 18
CR - Costa Rica 17
NP - Nepal 17
GR - Grecia 16
HU - Ungheria 16
PY - Paraguay 16
KG - Kirghizistan 15
TT - Trinidad e Tobago 15
DK - Danimarca 14
HN - Honduras 14
ET - Etiopia 13
KZ - Kazakistan 13
PA - Panama 13
AL - Albania 11
GT - Guatemala 11
TW - Taiwan 11
BH - Bahrain 10
OM - Oman 10
BO - Bolivia 9
SN - Senegal 9
SV - El Salvador 9
GH - Ghana 8
LB - Libano 8
NG - Nigeria 8
EE - Estonia 7
NI - Nicaragua 7
NO - Norvegia 7
PR - Porto Rico 7
PS - Palestinian Territory 7
RS - Serbia 7
SY - Repubblica araba siriana 7
BY - Bielorussia 5
DO - Repubblica Dominicana 5
KH - Cambogia 5
MD - Moldavia 5
SI - Slovenia 5
YE - Yemen 5
BS - Bahamas 4
GE - Georgia 4
KW - Kuwait 4
Totale 52.101
Città #
Ashburn 2.686
Fairfield 2.484
Southend 2.476
Singapore 2.262
Santa Clara 2.201
Woodbridge 1.619
Hong Kong 1.424
Houston 1.278
Jacksonville 1.156
Hefei 1.107
Chandler 1.040
Seattle 927
Wilmington 847
Ann Arbor 771
Cambridge 751
San Jose 713
Council Bluffs 662
Dearborn 655
Beijing 611
London 595
Los Angeles 529
Nyköping 500
Chicago 432
Ho Chi Minh City 375
The Dalles 364
Helsinki 344
Modena 340
Seoul 314
Hanoi 281
Buffalo 242
San Diego 239
Princeton 236
Milan 232
Sofia 217
New York 209
Eugene 187
Lauterbourg 183
Columbus 164
Izmir 163
Dallas 160
Salt Lake City 160
Shanghai 114
Munich 112
Moscow 110
São Paulo 105
Des Moines 94
Rome 90
Orem 87
Bologna 75
Frankfurt am Main 75
Guangzhou 75
Boardman 74
Elk Grove Village 73
Dublin 70
Tampa 68
Bremen 67
Atlanta 66
Redwood City 65
Tokyo 62
Jakarta 59
San Francisco 59
Phoenix 57
Haiphong 52
Kent 50
Naples 47
Da Nang 46
Montreal 46
Warsaw 45
Denver 44
Mexico City 44
Brooklyn 43
Norwalk 43
Philadelphia 43
Miano 41
Rio de Janeiro 41
Istanbul 40
Miami 40
Detroit 39
Turku 39
North Bergen 38
Baghdad 37
Falls Church 37
Lancaster 36
Toronto 36
Boston 33
Sterling 33
Chennai 32
Florence 31
Cagliari 30
Johannesburg 30
Parma 28
Dhaka 27
Mumbai 27
Redondo Beach 27
Amsterdam 26
Belo Horizonte 26
Cairo 26
Turin 26
Verona 26
Charlotte 25
Totale 35.173
Nome #
Combined myo-inositol and Banaba (1% Corosolic Acid) improve HOMA-IR and hepatic insulin extraction index in overweight and obese postmenopausal women 683
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 673
Inositol as putative integrative treatment for PCOS 612
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 539
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 463
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 422
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 410
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 393
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 389
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 389
Alla scoperta dei minerali dell'Isola d'Elba: itinerari e note per la ricerca sulle pegmatiti del Monte Capanne 381
Improved insulin sensitivity and reproductive profile in overweight/obese PCOS patients undergoing integrative treatment with carnitines, L-arginine, L-cysteine and myo-inositol 355
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 349
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 341
Diagnostic and therapeutic approach to hypothalamic amenorrhea 336
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 333
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 330
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 328
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 326
Use of metformin in the treatment of polycystic ovary syndrome 324
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 324
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 322
Inositol and human reproduction. From cellular metabolism to clinical use 318
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women 318
Life events impact in patients with secondary amenorrhoea. 313
Allopregnanolone concentrations and premenstrual syndrome 311
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 311
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 309
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 309
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 308
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 305
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 304
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 303
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 295
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 295
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 295
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 291
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 288
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 288
Advances in neurosteroids: Role in clinical practice 287
The relevance of inositols treatment for PCOS before and during ART 287
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 285
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 281
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 279
Subclinical Atherosclerosis at Peripheral Arteries in Obese Individuals. 278
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 275
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 275
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 275
Obesità e benessere: i rischi per la salute della donna obesa 272
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 271
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 267
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 265
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 263
Functional Hypothalamic Amenorrhea as Stress Induced Defensive System 261
Adrenal function under long-term raloxifene administration 259
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 259
Episodic secretion of activin A in pregnant women 257
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 251
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 249
Alpha lipoic acid administration improved both peripheral sensitivity to insulin and liver clearance of insulin reducing potential risk of diabetes and nonalcoholic fatty liver disease in overweight/obese PCOS patients 248
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 247
Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both 247
Neuroendocrinological Aspects of a Tailored Hormonal Contraception 246
Cranberry, D-mannose and anti-inflammatory agents prevent lower urinary tract symptoms in women undergoing prolapse surgery 246
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 244
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 243
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 242
DHEA as a putative replacement therapy in the elderly 242
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 241
Corticotropin-releasing factor-binding protein: Origins and possible functions 241
Long-term GnRH-agonist administration revealed a GnRH-independent mechanism stimulating FSH discharge in humans 240
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 239
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 239
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 238
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 238
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 238
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 238
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 236
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 235
Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study 235
Effects of red clover extracts on breast cancer cell migration and invasion 235
Female precocious puberty, obesity and polycystic-like ovaries 233
Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome 232
Endocrine and clinical effects of myo-inositol administration in policystyc ovary syndrome. A randomized study. 231
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 230
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 229
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 228
Progestinici e fibromatosi uterina 226
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 226
Aspetti endocrini, diagnostici e terapeutici delle menimetrorragie in età perimenopausale. 225
Effect of short term sibutramine on gonadotropin spontaneous pulsatile release in normogonadotropinemic amenorrheic subjects 225
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 225
Which form of HRT should we choose? 224
Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules 224
Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study 223
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 222
Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty 221
. Opioid control of gonadotrophin secretion in humans. 221
Acetyl-L-Carnitine effect on pituitary and plasma *-endorphin responsiveness to different chronic intermittent stressors. 221
Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss 220
Totale 29.163
Categoria #
all - tutte 210.079
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.079


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.779 0 0 352 284 63 116 277 198 345 211 533 400
2022/20233.137 348 269 172 271 391 517 52 285 422 45 150 215
2023/20242.303 92 145 141 152 551 197 242 315 36 72 145 215
2024/20257.938 334 105 80 608 1.507 1.010 355 487 1.067 720 763 902
2025/202616.663 1.044 714 1.610 1.644 2.192 1.300 1.906 897 1.678 1.562 1.127 989
2026/20273.617 1.456 2.033 128 0 0 0 0 0 0 0 0 0
Totale 52.529